中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 6
Jun.  2017
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2017  >  33(6): 1033-1039

A comparison of 2015 and 2016 EASL guidelines on treatment of hepatitis C: an analysis of direct-acting antiviral agents and drug-drug interaction

DOI: 10.3969/j.issn.1001-5256.2017.06.003
Research funding:

 

  • Published Date: 2017-06-20
    Abstract
    • FullText(HTML)
  • loading
    • References(6)
  • [1]SULKOWSKI MS, GARDINER DF, RODRIGUEZ-TORRES M, et al.Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection[J].New Engl J Med, 2014, 370 (3) :211-221.
    [2]OMATA M, KANDA T, WEI L, et al.APASL consensus statements and recommendation on treatment of hepatitis C[J].Hepatol Int, 2016, 10 (5) :702-726.
    [3]European Association for the Study of the Liver.EASL recommendations on treatment of hepatitis C 2015[J].J Hepatol, 2015, 63 (1) :199-236.
    [4] European Association for the Study of the Liver.EASL recommendations on treatment of hepatitis C 2016[J].J Hepatol, 2017, 66 (1) :153-194.
    [5]RAO HY, WEI L.EASL recommendations on treatment of hepatitis C 2015[J].J Clin Hepatol, 2015, 31 (7) :1008-1017. (in Chinese) 饶慧瑛, 魏来.2015年欧洲肝病学会丙型肝炎治疗推荐意见[J].临床肝胆病杂志, 2015, 31 (7) :1008-1017.
    [6]AASLD/IDSA HCV Guideance Panel.Hepatitis C guidance:AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus[J].Hepatology, 2015, 62 (3) :932-954.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (2567) PDF downloads(550) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return